NPC Archive Item: Cardiovascular safety of anticholinergics in COPD

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 25 March 2010 A US cohort study in patients with COPD found an increased risk of CV events associated with the use of ipratropium within the past six months. […]

NPC Archive Item: Drug Safety Update from MHRA/CHM (February 2010)

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. The Drug Safety Update is an NHS Evidence accredited provider 19 February 2010 The MHRA and CHM have published the February edition of Drug Safety Update This edition includes […]

NPC Archive Item: Observational data in swine influenza pandemic indicate benefit of early antivirals; new Cochrane review finds oseltamivir▼’s ability to prevent complications of seasonal influenza in otherwise healthy adults not proven.

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 22 December 2009 Action Health professionals’ responses to the swine influenza pandemic should not be affected by the controversy regarding oseltamivir▼’s ability to prevent complications of seasonal influenza in […]

NPC Archive Item: Roflumilast in COPD

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 18 November 2009, Two one-year RCTs (AURA and HERMES) showed that roflumilast modestly improved lung function in patients with severe COPD who were symptomatic and not using an inhaled […]

NPC Archive Item: Triple versus single therapy in COPD

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 4 November 2009 A short-term randomised controlled trial claims benefits for the addition of inhaled budesonide/formoterol to tiotropium (i.e. triple vs. single therapy) in patients with COPD. However, limitations […]